In that same study, AntiGan reduced alpha-fetoprotein (AFP) and carcinoembryonic antigen (CEA) levels; AFP is a marker for hepatocellular carcinoma and CEA is a marker for gastrointestinal cancer [35]. The gene discussed is AFP; the disease is hepatocellular carcinoma.